SUMMARY
Background The application of nutritional ultrasound for the morphological and structural study of muscle mass is an emerging technique in clinical nutrition. Currently, all definitions of malnutrition include the measurement of muscle mass involvement, however, there is no single way to assess it. It is necessary to develop new techniques to identify muscle involvement in malnutrition that are valid, standardized, reliable, accurate and profitable.
Objectives The objective of this study is to value the new muscle ultrasound techniques aimed to measure muscle and functional status, to make a more accurate diagnosis and a better prediction of complications and morbidity and mortality in patients at nutritional risk. Primary outcome: to assess the feasibility of ultrasound or muscle ultrasound techniques in both nutritional diagnosis and follow-up, over 3 to 6 months, in a nutritional intervention program.
Methods DRECO (Disease-Related caloric-protein malnutrition EChOgraphy) is a prospective, multicenter, uncontrolled clinical study in standard clinical practice to value the usefulness of nutritional ultrasound (muscle ultrasound) in the nutritional diagnosis and follow-up of patients over a period of 3 to 6 consecutive months, after standard nutritional clinical practice intervention, and physical activity to control their disease-related malnutrition.
Discussion This study will standardize nutritional ultrasound measures. It will validate and define specific cut-off values for nutritional ultrasound and get its correlation with already well-known nutritional tools such as SGA (Subjective Global Assessment) or GLIM (Global Leadership Initiative on Malnutrition) criteria. Thus, muscle ultrasound will become not only a tool to assess the diagnosis of malnutrition, but it will be integrated in the routine clinical practices to evaluate nutritional interventions.
Registration This study is registered at clinicaltrials.gov (NCT05433831), registered on June 27th, 2022. https://clinicaltrials.gov/ct2/show/NCT05433831.
Competing Interest Statement
The authors have declared that no competing interests exist. An ICMJE DISCLOSURE FORM for each author is submitted.
Clinical Trial
This study is registered at clinicaltrials.gov (NCT05433831), registered on June 27th, 2022. https://clinicaltrials.gov/ct2/show/NCT05433831.
Funding Statement
Funding: This study will be conducted thanks to a research grant from Abbott Laboratories. Conflicts of Interest: JM.G.A., D.B.G, D.L.R, and G.O.F declare no conflict of interest. G.G.R is an employee of Abbott Laboratories.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board Statement: The study was conducted in accordance with the Decla-ration of Helsinki, and approved by the following Ethical Committees: Comité de ética de la In-vestigación Provincial De M álaga, Comité de ética de la Investigación con medicamentos Área De Salud Valladolid, Comité de ética de la Investigación provincial de Córdoba, Comité de ética de la Investigación con medicamentos del Complejo Hospitalario Universitario de Canarias (Provincia de Santa Cruz de Tenerife), Comité de ética de la Investigación con medicamentos del Complejo Hospitalario Universitario de Las Palmas, Comité de ética de la Investigación con medicamentos y Comisión de Proyectos de Investigación del Hospital Universitari Vall D’Hebron, Comité de ética de la Investigación con medicamentos del Consorcio Hospital General Universitario de Valencia, Comité de ética de la Investigación con medicamentos de la Clínica de Navarra, Comité de ética de la Investigación con medicamentos de Euskadi and Comité de ética de la Investigación con medicamentos del Hospital Universitario y Politécnico la Fe de Valencia. This study is registered at clinicaltrials.gov (NCT05433831), registered on June 27th, 2022. https://clinicaltrials.gov/ct2/show/NCT05433831.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
jgarciaalmeida{at}gmail.com, diegobellido{at}gmail.com, dadluis{at}yahoo.es, german.guzman1{at}abbott.com, gabrielm.olveira.sspa{at}juntadeandalucia.es
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.